These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8358060)

  • 1. Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-alpha.
    Kudelka AP; Freedman RS; Edwards CL; Lippman SM; Tornos CS; Krakoff IH; Kavanagh JJ
    Anticancer Drugs; 1993 Jun; 4(3):335-7. PubMed ID: 8358060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinoma.
    Pazdur R; Bready B; Ajani JA; Abbruzzese JL; Markowitz A; Sugarman S; Jones D; Levin B
    Am J Clin Oncol; 1995 Oct; 18(5):436-8. PubMed ID: 7572763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
    Enzinger PC; Ilson DH; Saltz LB; Martin LK; Kelsen DP
    Cancer; 1999 Mar; 85(6):1213-7. PubMed ID: 10189124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
    Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
    J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
    Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
    J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II pilot trial of 13-cis retinoic acid and interferon-alpha in patients with advanced pancreatic carcinoma.
    Brembeck FH; Schoppmeyer K; Leupold U; Gornistu C; Keim V; Mössner J; Riecken EO; Rosewicz S
    Cancer; 1998 Dec; 83(11):2317-23. PubMed ID: 9840531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
    Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
    Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer.
    Voravud N; Lippman SM; Weber RS; Rodriquez GI; Yee D; Dimery IW; Earley CL; Von Hoff DD; Hong WK
    Invest New Drugs; 1993 Feb; 11(1):57-60. PubMed ID: 8349437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
    Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature.
    Piamsomboon S; Termrungruanglert W; Kudelka AP; Edwards CL; Freedman RS; Mountain CF; Delclos L; Aapro MS; DeCaro L; Bianca J; Verschraegen CF; Kavanagh JJ
    Anticancer Drugs; 1996 Sep; 7(7):800-4. PubMed ID: 8949994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.
    Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ
    Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
    Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
    Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.
    Shin DM; Glisson BS; Khuri FR; Clifford JL; Clayman G; Benner SE; Forastiere AA; Ginsberg L; Liu D; Lee JJ; Myers J; Goepfert H; Lotan R; Hong WK; Lippman SM
    J Clin Oncol; 2002 Jan; 20(2):364-70. PubMed ID: 11786562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
    Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Massimini G; Holdener EE; Krakoff IH
    J Natl Cancer Inst; 1993 Mar; 85(6):499-500. PubMed ID: 8445678
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin.
    Fleming GF; O'Brien SM; Hoffman PC; Vokes EE; Vogelzang NJ; Schilsky RL; Waggoner SE; Ratain MJ
    Cancer Chemother Pharmacol; 1997; 39(3):227-32. PubMed ID: 8996525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
    Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
    J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced clear cell carcinoma of the endometrium that responded remarkably to neoadjuvant chemotherapy of combination carboplatin plus weekly paclitaxel].
    Takami M; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Sakamoto H; Yamamoto T
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):457-60. PubMed ID: 17353643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951).
    Aass N; De Mulder PH; Mickisch GH; Mulders P; van Oosterom AT; van Poppel H; Fossa SD; de Prijck L; Sylvester RJ
    J Clin Oncol; 2005 Jun; 23(18):4172-8. PubMed ID: 15961764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma.
    Dhingra K; Papadopoulos N; Lippman S; Lotan R; Legha SS
    Invest New Drugs; 1993 Feb; 11(1):39-43. PubMed ID: 8349434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.